• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

55
49
43
39
11

COUNTRY

11
11
11
11
10

CATEGORIES

  • 66
  • 23
  • 11
  • 9
  • 8
  • 7
  • 7
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

19
21
24
117

PUBLISHED

10
11
44
117

PRODUCT TYPE

79
20
16
1
1

Search "Proteomics of the Nervous System" returned 117 results.

PRODUCT TITLE
Proteomics - Technologies, Markets and Companies Proteomics - Technologies, Markets and Companies - Product Thumbnail Image

Proteomics - Technologies, Markets and Companies

This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first...

April 2014
FROM
Central Nervous System Partnering Terms and Agreements Central Nervous System Partnering Terms and Agreements - Product Thumbnail Image

Central Nervous System Partnering Terms and Agreements

The Central Nervous System Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the central nervous system partnering deals and agreements entered...

March 2014
FROM
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders Drugs may be administered directly into the CNS or administered systematically (e g ,...

April 2014
FROM
Biomarkers - Global Strategic Business Report Biomarkers - Global Strategic Business Report - Product Thumbnail Image

Biomarkers - Global Strategic Business Report

This report analyzes the worldwide markets for Biomarkers in US$ Million by the following Technologies and Services: Technologies - Emerging Biomarker Technologies (Imaging biomarkers, Proteomics, Transcriptomics,...

August 2011
FROM
Biomarkers - Technologies, Markets and Companies Biomarkers - Technologies, Markets and Companies - Product Thumbnail Image

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

April 2014
FROM
Neuroprotection - Drugs, Markets and Companies Neuroprotection - Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Drugs, Markets and Companies

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many...

April 2014
FROM
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future Considerable...

April 2014
FROM
Molecular Diagnostics - Technologies, Markets and Companies Molecular Diagnostics - Technologies, Markets and Companies - Product Thumbnail Image

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

April 2014
FROM
Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics - Product Thumbnail Image

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing...

November 2013
FROM
09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in September 2012 All companies include technology, market(s), key...

September 2012
FROM

Neural Degeneration and Repair. Gene Expression Profiling, Proteomics and Systems Biology

With contributions from leading scientists around the world, this is the first book focussing on the analysis of nerve cell damage and repair using genomics, transcriptomics, proteomics and systems...

February 2008
European Biomarker Analysis Market European Biomarker Analysis Market - Product Thumbnail Image

European Biomarker Analysis Market

This research service gives a detailed analysis of the biomarker analysis market in Europe from 2005-2015 This Frost & Sullivan research service titled European Biomarker Analysis Market provides revenue...

September 2009
FROM
Cell Therapy - Technologies, Markets and Companies Cell Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine Hematopoietic stem cell transplantation is...

April 2014
FROM

DNA Microarray 2013: A Focus on Sales Growth

Summary: This market analysis was carried out to provide business information to developers, manufacturers and suppliers in the DNA microarray field Its findings include: - Marketing and sales opportunities...

February 2013
FROM
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics - Product Thumbnail Image

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

The Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the asset purchase agreements entered into...

April 2014
FROM
CompetitiveWatch Molecular Diagnostics: Strategic Assessments of Major Suppliers CompetitiveWatch Molecular Diagnostics: Strategic Assessments of Major Suppliers - Product Thumbnail Image

CompetitiveWatch Molecular Diagnostics: Strategic Assessments of Major Suppliers

The “CompetitiveWatch Nucleic Acid Testing: Strategic Profiles of Leading Suppliers” report presents insightful analyses of major current and emerging suppliers of molecular diagnostic products in terms...

May 2013
FROM
CompetitiveWatch Nucleic Acid Testing: Strategic Profiles of Leading Suppliers CompetitiveWatch Nucleic Acid Testing: Strategic Profiles of Leading Suppliers - Product Thumbnail Image

CompetitiveWatch Nucleic Acid Testing: Strategic Profiles of Leading Suppliers

This 549-page report on “CompetitiveWatch Nucleic Acid Testing: Strategic Profiles of Leading Suppliers” presents an overview of the clinical significance and market needs for major current and emerging...

May 2013
FROM
Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers - Product Thumbnail Image

Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers

This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing...

September 2012
FROM

Toxoplasma Gondii. Edition No. 2

This 2e of Toxoplasma gondii reflects the significant advances in the field in the last 5 years, including new information on the genomics, epigenomics and proteomics of T. gondii as well as a new understanding...

August 2013
Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics - Product Thumbnail Image

Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering...

April 2014
FROM
Loading Indicator